558 related articles for article (PubMed ID: 28803404)
61. Association of NER pathway gene polymorphisms with susceptibility to laryngeal cancer in a Chinese population.
Sun Y; Tan L; Li H; Qin X; Liu J
Int J Clin Exp Pathol; 2015; 8(9):11615-21. PubMed ID: 26617899
[TBL] [Abstract][Full Text] [Related]
62. ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population.
Justenhoven C; Hamann U; Pesch B; Harth V; Rabstein S; Baisch C; Vollmert C; Illig T; Ko YD; Brüning T; Brauch H
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2059-64. PubMed ID: 15598761
[TBL] [Abstract][Full Text] [Related]
63. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.
Srivastava DS; Mandhani A; Mittal RD
Arch Toxicol; 2008 Sep; 82(9):633-9. PubMed ID: 18200441
[TBL] [Abstract][Full Text] [Related]
64. Genetic polymorphisms in the DNA repair genes XPD and XRCC1, p53 gene mutations and bladder cancer risk.
Gao W; Romkes M; Zhong S; Nukui T; Persad RA; Smith PJ; Branch R; Keohavong P
Oncol Rep; 2010 Jul; 24(1):257-62. PubMed ID: 20514470
[TBL] [Abstract][Full Text] [Related]
65. Association of XPD (Lys751Gln) and XRCC1 (Arg280His) gene polymorphisms in myelodysplastic syndrome.
Joshi D; Korgaonkar S; Shanmukhaiah C; Vundinti BR
Ann Hematol; 2016 Jan; 95(1):79-85. PubMed ID: 26482462
[TBL] [Abstract][Full Text] [Related]
66. Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility.
Andrew AS; Nelson HH; Kelsey KT; Moore JH; Meng AC; Casella DP; Tosteson TD; Schned AR; Karagas MR
Carcinogenesis; 2006 May; 27(5):1030-7. PubMed ID: 16311243
[TBL] [Abstract][Full Text] [Related]
67. DNA repair gene polymorphisms and bladder cancer susceptibility in a Turkish population.
Karahalil B; Kocabas NA; Ozçelik T
Anticancer Res; 2006; 26(6C):4955-8. PubMed ID: 17214369
[TBL] [Abstract][Full Text] [Related]
68. Impact of nucleotide excision repair ERCC2 and base excision repair APEX1 genes polymorphism and its association with recurrence after adjuvant BCG immunotherapy in bladder cancer patients of North India.
Gangawar R; Ahirwar D; Mandhani A; Mittal RD
Med Oncol; 2010 Jun; 27(2):159-66. PubMed ID: 19242824
[TBL] [Abstract][Full Text] [Related]
69. Association of DNA repair gene XRCC1 and XPD polymorphisms with genetic susceptibility to gastric cancer in a Chinese population.
Yuan T; Deng S; Chen M; Chen W; Lu W; Huang H; Xia J
Cancer Epidemiol; 2011 Apr; 35(2):170-4. PubMed ID: 20863780
[TBL] [Abstract][Full Text] [Related]
70. The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development.
Rouissi K; Bahria IB; Bougatef K; Marrakchi R; Stambouli N; Hamdi K; Cherif M; Ben Slama MR; Sfaxi M; Othman FB; Chebil M; Elgaaied AB; Ouerhani S
BMC Cancer; 2011 Mar; 11():101. PubMed ID: 21426550
[TBL] [Abstract][Full Text] [Related]
71. Inter-ethnic differences in genetic polymorphisms of xenobiotic-metabolizing enzymes (CYP1A1, CYP2D6, NAT1 and NAT2) in healthy populations: correlation with the functional in silico prediction.
Khlifi R; Ben Salah G; Chakroun A; Hamza-Chaffai A; Rebai A
Mol Biol Rep; 2014 Sep; 41(9):5735-43. PubMed ID: 24934312
[TBL] [Abstract][Full Text] [Related]
72. Base excision repair pathway genes polymorphism in prostate and bladder cancer risk in North Indian population.
Mittal RD; Mandal RK; Gangwar R
Mech Ageing Dev; 2012 Apr; 133(4):127-32. PubMed ID: 22019847
[TBL] [Abstract][Full Text] [Related]
73. Polymorphisms in DNA repair genes and breast cancer risk in Russian population: a case-control study.
Shadrina AS; Ermolenko NA; Boyarskikh UA; Sinkina TV; Lazarev AF; Petrova VD; Filipenko ML
Clin Exp Med; 2016 Feb; 16(1):21-8. PubMed ID: 25537147
[TBL] [Abstract][Full Text] [Related]
74. Tobacco carcinogen-metabolizing genes CYP1A1, GSTM1, and GSTT1 polymorphisms and their interaction with tobacco exposure influence the risk of head and neck cancer in Northeast Indian population.
Choudhury JH; Singh SA; Kundu S; Choudhury B; Talukdar FR; Srivasta S; Laskar RS; Dhar B; Das R; Laskar S; Kumar M; Kapfo W; Mondal R; Ghosh SK
Tumour Biol; 2015 Aug; 36(8):5773-83. PubMed ID: 25724184
[TBL] [Abstract][Full Text] [Related]
75. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
76. XRCC1 codon 280 and ERCC2 codon 751 polymorphisms and risk of esophageal squamous cell carcinoma in a Chinese population.
Zhai XD; Mo YN; Xue XQ; Zhao GS; Gao LB; Ai HW; Ye Y
Bull Cancer; 2009 Oct; 96(10):E61-5. PubMed ID: 19762325
[TBL] [Abstract][Full Text] [Related]
77. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
78. Polymorphisms of the XRCC1 and XPD genes and breast cancer risk: a case-control study.
Kipikasová L; Wolaschka T; Bohus P; Baumohlová H; Bober J; Blazejová J; Mirossay L; Sarisský M; Mirossay A; Cizmáriková M; Potoceková D; Mojzis J
Pathol Oncol Res; 2008 Jun; 14(2):131-5. PubMed ID: 18415712
[TBL] [Abstract][Full Text] [Related]
79. Polymorphisms of DNA repair genes XPD, XRCC1, and OGG1, and lung adenocarcinoma susceptibility in Chinese population.
Ouyang FD; Yang FL; Chen HC; Khan MA; Huang FM; Wan XX; Xu AH; Huang X; Zhou MJ; Fang Q; Zhang DZ
Tumour Biol; 2013 Oct; 34(5):2843-8. PubMed ID: 23700156
[TBL] [Abstract][Full Text] [Related]
80. Association of DNA repair and xenobiotic pathway gene polymorphisms with genetic susceptibility to gastric cancer patients in West Bengal, India.
Ghosh S; Ghosh S; Bankura B; Saha ML; Maji S; Ghatak S; Pattanayak AK; Sadhukhan S; Guha M; Nachimuthu SK; Panda CK; Maity B; Das M
Tumour Biol; 2016 Jul; 37(7):9139-49. PubMed ID: 26768611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
